ALHC Alignment Healthcare, Inc. - Fundamental Analysis
BEARISH
Sign in to save
Save this symbol to a watchlist or track a position.
ALHC Stock | Fundamental Analysis & Investment Insights
NASDAQ
Healthcare
Healthcare Plans
Current Price
Live
$19.22
Analyst Target
$25.42
+32.2%
Upside
52W High
$23.87
52W Low
$11.62
At a glance
Key valuation, profitability, growth, and risk metrics.
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
85%
Analysis Accuracy
ALHC's Advanced Deterministic Scorecard reveals significant financial health concerns, with a Piotroski F-Score of 2/9 indicating weak operational and financial stability. The absence of an Altman Z-Score and the company's high debt/equity ratio of 1.84 raise distress risk concerns, especially given negative profitability metrics and a lack of positive cash flow indicators. Despite strong revenue growth (44.4% YoY) and impressive earnings surprises in recent quarters, the company remains unprofitable with negative ROE (-0.70%) and ROA (1.00%), undermining long-term sustainability. Insider selling totaling $454.78M over six months signals strong bearish sentiment from leadership, further eroding confidence. The stock trades at a premium valuation (Price/Book: 21.89) despite poor profitability, suggesting overvaluation relative to fundamentals.
Key Strengths
Strong revenue growth of 44.4% YoY, indicating market expansion and execution capability
Exceptional earnings surprise history with average 458.81% beat in last 4 quarters
Positive recent EPS growth (Q/Q: +42.9%, YoY: +171.4%) signaling improving profitability trajectory
High analyst target price of $25.42 implies strong growth optimism despite current losses
Gross margin of 12.37% suggests some pricing power and cost control in operations
Key Risks
Piotroski F-Score of 2/9 indicates severe financial distress signals and weak operational efficiency
Negative ROE (-0.70%) and ROA (1.00%) reflect poor capital utilization and unprofitability
Debt/Equity ratio of 1.84 is high, especially for a loss-making company with no clear path to profitability
Insider selling of $454.78M in 6 months signals lack of confidence from leadership
No available cash flow or dividend data, suggesting potential liquidity strain and no return to shareholders
Performance Snowflake
Multi-dimensional AI analysis across 5 key categories
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Historical Performance Trends
Long-term financial metrics and growth patterns
Valuation Metrics
Key valuation ratios and pricing indicators
Profitability, Growth & Financial Health
Detailed profit margins, ROE, debt ratios, and liquidity metrics
Sector Comparison & Peer Analysis
Compare ALHC against industry averages and similar companies
Insider Trading & Analyst Ratings
Track insider transactions and Wall Street analyst recommendations
Past News Coverage
Recent headlines mentioning ALHC from our newsroom.
Newest → oldest
No matching news yet.